Medical terminology has often confused some of the everyday health conditions related to a body part. Several terms, notably ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Glutamatergic medications are linked to significant symptom improvement in obsessive-compulsive and related disorders, a new ...

IntroductionMental Health is not a taboo topic anymore. With many people, especially celebrities in India and abroad, ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...

For adults with opioid use disorder (OUD) receiving buprenorphine, a mindfulness-based group is similar to a recovery support ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

A study found that older adults with anxiety may have an increased risk of developing dementia—but this risk decreased once ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...

Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...